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In the Amazon Region, there is a virtual absence of severe malaria and few fatal cases of naturally occurring 
Plasmodium falciparum infections; this presents an intriguing and underexplored area of research. In addition to the 
rapid access of infected persons to effective treatment, one cause of this phenomenon might be the recognition of cy-
toadherent variant proteins on the infected red blood cell (IRBC) surface, including the var gene encoded P. falciparum 
erythrocyte membrane protein 1. In order to establish a link between cytoadherence, IRBC surface antibody recogni-
tion and the presence or absence of malaria symptoms, we phenotype-selected four Amazonian P. falciparum isolates 
and the laboratory strain 3D7 for their cytoadherence to CD36 and ICAM1 expressed on CHO cells. We then mapped 
the dominantly expressed var transcripts and tested whether antibodies from symptomatic or asymptomatic infections 
showed a differential recognition of the IRBC surface. As controls, the 3D7 lineages expressing severe disease-asso-
ciated phenotypes were used. We showed that there was no profound difference between the frequency and intensity 
of antibody recognition of the IRBC-exposed P. falciparum proteins in symptomatic vs. asymptomatic infections. The 
3D7 lineages, which expressed severe malaria-associated phenotypes, were strongly recognised by most, but not all 
plasmas, meaning that the recognition of these phenotypes is frequent in asymptomatic carriers, but is not necessarily 
a prerequisite to staying free of symptoms.
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Plasmodium falciparum is the causative agent of the 
most dangerous form of malaria, a disease that affects 
approximately 200 million people every year in tropical 
areas of the world (WHO 2013). Immunity against ma-
laria is only acquired after successive malaria episodes 
and is strongly dependent on the generation of specific 
B-cells, antibodies and a functional T-cell memory re-
sponse (Marsh & Kinyanjui 2006, Crompton et al. 2010, 
Weiss et al. 2010, Portugal et al. 2013). Multiple targets 
of antibodies have been identified on the merozoite sur-
face or localised to organelles within it and many of 
them are being considered as potential vaccine compo-
nents (Vaughan & Kappe 2012). The infected red blood 
cells (IRBCs) and the variant parasite proteins directed 
to its surface are also important targets for antibodies 
and it has been shown that cumulative exposure increas-
es the breadth of the recognition of antigenic variants 
that are displayed (Hviid 2005). A major portion of an-
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tibodies seems to be directed against variants of the P. 
falciparum erythrocyte membrane protein 1 (PfEMP1) 
(Leech et al. 1984, Bull et al. 1998, Chan et al. 2012), 
which are important virulence factors because they me-
diate the cytoadhesion of IRBCs to a variety of receptors 
found in endothelial tissues [reviewed in Pasternak and 
Dzikowski (2009)], thus allowing the IRBCs to avoid 
spleen clearance. PfEMP1 variants are encoded by the 
var gene family and consist of 50-60 alleles per haploid 
genome (Baruch et al. 1995, Su et al. 1995); they are 
expressed in such a way so that only one or a few var 
gene loci (Joergensen et al. 2010) are active per infected 
RBC, leading to the exposure of only one (or a few) spe-
cies of PfEMP1. In a timely fashion, the var gene locus 
activation is altered by chromatin modification so that 
PfEMP1 expression switches [reviewed by Guizetti and 
Scherf (2013)]. This leads to a constant immune evasion 
of the circulating IRBCs, which is termed antigenic vari-
ation. Due to the accelerated genetic recombination of 
var genes (Freitas-Júnior et al. 2000), the diversity of var 
genes in field isolates is very high [e.g., data described 
in Warimwe et al. (2009)] turning the task of developing 
antibodies against most of the variants into a long-last-
ing process. Importantly, most of the circulating variants 
show cytoadherence to CD36 and the presence of this 
phenotype was associated with non-severe malaria epi-
sodes (Ochola et al. 2011). Despite the great diversity of 
P. falciparum IRBC antibody recognition • Alessandra Sampaio Bassi Fratus et al. 599
var genes and PfEMP1 variants, a number of alleles are 
fairly conserved between different isolates. An example 
of this are the var genes, which encode PfEMP1 ver-
sions expressed in pregnancy-associated malaria (PAM) 
(var2csa) (Lavstsen et al. 2003, Salanti et al. 2003); the 
recognition of these variants is associated with the de-
crease of PAM symptoms (Tutterrow et al. 2012). Anoth-
er conserved group of var domains was recently revealed 
by the comparison of seven P. falciparum genomes 
(Rask et al. 2010). Three independent groups showed 
that up-regulation of the var genes expressing domain 
cassettes 8 (DC8) or DC 13 domains occurred in cases 
of severe childhood malaria (Avril et al. 2012, Claessens 
et al. 2012, Lavstsen et al. 2012). The receptor for these 
domains appears to be the endothelial protein C receptor 
(EPCR) (Turner et al. 2013). Another conserved pheno-
type of PfEMP1 encoded by DC4 domains (Oleinikov et 
al. 2009, Bengtsson et al. 2013) seems to be associated 
with ICAM1-binding, which itself was correlated with 
severe (cerebral) malaria (Turner et al. 1994). Very little 
is known about the adhesion binding properties and an-
tigenic variation related to the var genes and PfEMP-1 
proteins in Amazonian isolates. Previous reports by our 
group based on the analysis of PfEMP1-DBLα encod-
ing tags showed that the var gene repertoires seem much 
smaller in Amazonian P. falciparum isolates compared 
to other endemic settings (Albrecht et al. 2006, 2010). It 
is also known that the absolute number of malaria-infect-
ed people in the Amazon may be underestimated due to 
a high incidence of asymptomatic infections in riverside 
settlements (Alves et al. 2002). Additionally, the occur-
rence of severe malaria is a rare event and seems to hap-
pen due to a late diagnosis outside the transmission area; 
consequently it is as lethal as in African settings. In ab-
solute numbers, the mortality rate of P. falciparum ma-
laria in Brazil is much lower than in Africa. Given a total 
of 265,000 cases and 76 deaths from malaria in Brazil in 
2011 the mortality rate of malaria in Brazil was 0.029% 
compared to 0.3% worldwide in the same year [655,000 
deaths out of 216 million cases worldwide in 2011 (WHO 
2011)]. Based on this information, we set out to explore 
whether the recognition of possibly less circulating an-
tigenic variants (due to redundant circulating var gene 
repertoires) by antibodies in patient sera were correlated 
to asymptomatic outcomes of malaria and whether the 
phenotype associated with severe malaria - a parasite line 
most likely expressing a DC8 domain encoding var gene - 
was recognised even in the virtual absence of severe ma-
laria. For this, we phenotype-selected four Amazonian P. 
falciparum isolates plus the non-related 3D7 strain based 
on the receptors CD36 and ICAM1 expressed on CHO 
cells. We then quantified IRBC recognition by plasma 
antibodies using flow cytometry.
SUBJECTS, MATERIALS AND METHODS
Human plasma samples from symptomatic and 
asymptomatic individuals - Human plasma samples were 
obtained during an epidemiological survey from persons 
living in the surroundings of Porto Velho, the capital of 
the state of Rondônia (RO) (Brazil). Ethical clearance 
was obtained from the Ethical Board of the Institute for 
Biomedical Sciences at São Paulo University and the 
Institute of Research on Tropical Pathologies before the 
start of the trial (protocol 741/2006). Each individual 
expressed his/her written consent to participate in the 
study. Participants were considered symptomatic when 
they presented with at least one clinical symptom (fever 
> 37.8ºC, prostration, headache, chills, tremors, myalgia, 
nausea and/or vomiting) and positive parasitaemia was 
tested by a thick blood smear and/or polymerase chain 
reaction (PCR). Individuals who did not present with 
any clinical symptoms for up to 30 days after the blood 
withdrawal, but had tested positive for P. falciparum by 
PCR, were considered to be asymptomatic. All patients 
were treated with the adequate drugs (Coartem) directly 
after the molecular diagnosis. In total, 89 plasma sam-
ples from symptomatic individuals and asymptomatic 
individuals (the latter were residents of Santo Antônio, 
Bate-Estaca and Vila Candelária, communities next to 
the Madeira River) were tested.
Parasites and static cytoadherence assay - P. falci-
parum field isolates S20, 99, 106 and 134 were collected 
in RO (Albrecht et al. 2006). While the S20 strain was 
originally collected and culture-adapted by Segurado et 
al. (1997), the 99, 106 and 134 isolates were collected and 
culture-adapted during an effort to map the genetic di-
versity of P. falciparum in the western Amazon Region, 
but without the aim of monitoring cytoadherent pheno-
types of the initial patient isolate [Research Project São 
Paulo State Research Foundation (01/09401-0)]. In con-
sequence, the initial phenotypes were lost and not avail-
able for this work. The 3D7 strain was initially received 
by Walliker et al. (1987). All parasites were cultured in 
candle jars as described (Trager & Jensen 1976) using 
RPMI-1640 medium supplemented with 10% human 
plasma (type A or AB) and O- erythrocytes. The para-
sites were selected for the expression of the determined 
PfEMP1 variants using static cytoadherence assays as 
described by Golnitz et al. (2008). Briefly, 108 tropho-
zoite infected RBCs were incubated over CHO-ICAM or 
CHO-CD36 cells (a generous gift from Dr Artur Scherf, 
Pasteur Institute, Paris) and were cultured to confluence 
in 25 cm2 culture bottles. Unbound parasites were then 
removed by three subsequent washings with RPMI at pH 
6.8 and the still-bound parasites were detached by incu-
bation with RPMI at pH 7.4 and cultivated with fresh 
RBCs. This procedure was repeated five times, after 
which a homogenous binding phenotype was achieved. 
To measure the achieved cytoadherence properties, 5 x 
105 CHO cells expressing either CD36 or ICAM1 were 
seeded in labtec slides and were grown for 48 h. Mature 
trophozoite/early schizont stage parasites were prepared 
from mixed cultures by plasmagel flotation (Lelievre et 
al. 2005). Cytoadherence was then measured by the in-
cubation of 5 x 106 trophozoite stage parasites over the 
cells for 1 h. After this, the supernatants were aspirated 
and the cells were washed three times with incomplete 
RPMI medium at pH 6.8. Next, the slides were stained 
and five fields were counted under a 1:1,000 magnifica-
tion. The parasite lines were judged clonal after testing 
11 microsatellites (Anderson et al. 1999) during previous 
research (L Albrecht, unpublished observations). The 
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3D7 lines, which dominantly transcribed var PF11_0521 
and PFD0020c, were identified after clonal selection 
using limiting dilution on previously CHO-CD36 and 
CHO-ICAM panned parasites, respectively.
Reverse transcription (RT)-PCR and sequencing 
analysis - For determining the dominant var transcript 
in field isolates and 3D7 parasites, the RNAs of 108 ring 
stage parasites were recovered from each parasite line 
using the Trizol® method (Invitrogen). All of the RNAs 
were submitted to RT using random hexamer primers 
and RevertAid Reverse Transcriptase (Fermentas) fol-
lowing the manufacturer’s instructions. Then, the DBLα 
tag sequences were amplified using the oligonucleotides 
also employed by Warimwe et al. (2009). The resulting 
~400 bp fragments were recovered from TAE-agarose 
gels and cloned into pGEM T-easy (Promega) vectors 
and 50 clones per lineage were sequenced in an ABI 
3100 (Applied Biosystems) automated DNA sequencer. 
The sequences were analysed using CLUSTALX 1.83 
and similarity to known DBLα tags was searched us-
ing the National Center for Biotechnology Information’s 
and PlasmoDBs BLAST (Altschul et al. 1997) website. 
The resulting DBLα tag sequences were then analysed 
for their distinct sequence identifiers (DSID) using the 
Perl script published by Bull et al. (2007). The DSID 
classification is based on the analysis of four semi-con-
served tetrapeptides (positions of limited variability) 
and the number of cysteines found in the DBLα region 
flanked by the oligonucleotides used herein, resulting 
in six groups of DSIDs. By comparison with the previ-
ously established classification of the 5’ untranslated re-
gions (UTR) of the var genes [upstream sequences (ups) 
(Lavstsen et al. 2003)], DBLα sequences of DSID groups 
1-3 were mostly associated with upsA type 5’-UTR se-
quences, while DSID groups 4-6 were associated with 
upsB and upsC 5’-UTR sequences (Bull et al. 2007).
Immunofluorescence - Live parasite immunofluores-
cence assays were conducted with enriched P. falciparum 
trophozoites and human plasmas from asymptomatic 
and symptomatic carriers. For this, trophozoite/schizont 
stage parasites were incubated with 40 µg/mL of 4’-6-
diamidino-2-phenylindole and HCS CellMask in 100 µL 
RPMI/1% bovine serum albumin for 60 min at 37ºC, fol-
lowed by incubation with plasma (dilution 1:25) and an 
Alexa Fluor labelled antihuman-IgG antibody (Molecular 
Probes, 1:200 dilution). Between each incubation step, the 
material was washed three times with RPMI pH 7.2 and 
was visualised in fluorescence microscopy. As a control, 
we employed the antiglycophorin antibody (1:1,000 dilu-
tion) (Molecular Probes) and a secondary antibody, anti-
mouse-IgG 1:500 (Alexa Fluor 594, Molecular Probes).
Flow cytometry - For the flow cytometry assays, the 
trophozoites were resuspended in RPMI pH 7.2 and 2% 
of bovine foetal serum (RPMI-S). Briefly, 5 x 106 para-
sites in blood at a parasitaemia of < 0.5% were incubated 
for 30 min with donor plasma, including as a control a 
plasma pool from persons who were never infected with 
malaria (1:10 dilution) in RPMI-S. This was immediately 
followed by antigoat IgG conjugated with Alexa Fluor 
488 (1:200 dilution) for 30 min. After that, the parasites 
were incubated with ethidium bromide [100 µg/mL in 
phosphate buffered saline (PBS) 1X] for 20 min to per-
form the nuclear labelling of the parasitised erythrocytes. 
After washing, the RBC solutions were resuspended in 
PBS to an average concentration of 500 cells per µL and 
were analysed in a Guava EasyCyte Mini flow cytom-
eter. For each plasma sample, 5,000 events were moni-
tored and analysed using the Guava EasySoft software. 
The surface labelling of the IRBCs was expressed as a 
reactivity index (RI). For this, we established a cut-off 
value that measured baseline surface labelling using the 
non-reactive pool of plasma samples against each para-
site lineage. Then, the average immunofluorescence val-
ues of each plasma sample measured in duplicate were 
divided by the average signal plus three standard devia-
tions obtained from the negative plasma pool. All plasma 
samples with RI above 1 were considered reactive.
Statistical analyses - All of the statistical analyses 
were performed using Prism GraphPad5 software. For 
the comparison of the ratio of responders/non-respond-
ers against phenotype-expressing parasite lines, Fisher’s 
exact test was applied. For the comparison of the RI val-
ues between different groups of plasma samples and/or 
parasite lines, Mann-Whitney’s U test was applied.
RESULTS
Cytoadherent-selected isolates show in part identi-
cal var DBLα sequences, but no selection of determined 
var type subclasses - In order to identify an association 
between var gene transcription and cytoadherent phe-
notypes in the Amazonian field isolates tested in this 
study, we used RT-PCR followed by cloning/sequencing 
of the amplified products. This is currently the only ap-
plicable non-high throughput method for var gene analy-
sis with unknown genome sequences. Fifty clones were 
sequenced per isolate and adhesive phenotype (CHO-
CD36 or CHO-ICAM), resulting in six-16 different se-
quences per isolate. All isolates showed one dominant 
DBLα sequence (Fig. 1). Severe malaria cases were re-
cently related to the expression of upsA-related DBLα 
sequences (Warimwe et al. 2009) and these fall into 
DSID groups 1-3 [defined by Bull et al. (2005, 2007)]. 
Accordingly, we classified the sequences according to 
their DSID group using the criteria developed by Bull 
et al. (2007) described above. The abundance of se-
quences with specific DSID types varied between para-
site lines. For example, the dominant sequence (46%) in 
the 3D7PFD0020c line was DSID type 1, while 38% were 
of DSID types 4-6 in this parasite line. However, pan-
ning of the parasites on CHO-ICAM, which should ide-
ally result in DBLα DSID type 3 (PF11_0521) express-
ing parasites, failed to result in such parasites and all 
parasites panned over this receptor showed only low 
frequencies of DBLα DSID 1-3 expressing parasites that 
were previously associated with severe malaria (Bull et 
al. 2005) (Fig. 1). Alignment of all the sequences also 
showed that highly similar var DBLα sequences (> 95% 
sequence identity) were identified in 106ICAM, S20ICAM 
and 99ICAM, indicating that at least the DBLα domains in 
the expressed PfEMP1 proteins seem similar, reinforc-
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ing the somehow redundant var repertoires in these par-
asites. Unexpectedly, the selection over CHO-CD36 in 
two cases led to the expression of dominant DSID type 
1-3 sequences in parasite lines S20 and 99. The selection 
of the 3D7 strain for CHO-ICAM adherence showed that 
the dominantly present var gene transcripts PFL1970w 
and PFD1000c were not exactly the ones identified pre-
viously by our group (Golnitz et al. 2008), nor were they 
PF11_0521, which contains the unique DBLβ/C2 domain 
that strongly interacts with ICAM1 in vitro (Oleinikov 
et al. 2009) or PFD1235w, as identified by Bengtsson et 
al. (2013). In fact, PFL1970w and PFD1000c do not even 
contain a DBLβ/C2 sequence at all (Rask et al. 2010), 
making their participation in ICAM1-binding doubtful. 
Selection of the 3D7 line on CHO-CD36 led to the ex-
pression of PFD0615c as previously published (Golnitz 
et al. 2008). We also tested two 3D7 lines that were pre-
viously encountered in cloning experiments and either 
expressed the var gene PFD0020c (3D7PFD0020c), which 
is associated with severe malaria (Lavstsen et al. 2012) 
or PF11_0521 (3D7PF11_0521), which contains the ICAM1 
binding domain (Oleinikov et al. 2009). In a second ap-
proach, we tried to identify whether any of the identi-
fied DBLα sequences were similar to DBLα domains 
Fig. 1: frequency of clones with var transcripts from different parasite lineages suggests the expression of few dominantly expressed var genes 
in each lineage. Shown are the frequencies of occurrence of determined var DBLα sequences which were obtained by reverse transcription-
polymerase chain reaction fragment cloning and sequencing of 50 clones per lineage. A: the frequency of sequence types in 3D7 parasite clones 
3D7PFD0020c and 3D7Pf11_0521; B: the frequencies of sequence types detected in 3D7 parasites panned over CHO-CD36 or CHO-ICAM1; C-F: the 
results from panned parasite isolates S20, 99, 106 and 134. The most frequently found transcript sequences per isolate are indicated together 
with their distinct sequence identifiers classification (bold) and the identity of the most similar DBLα tag DNA sequence from the 3D7 ge-
nome are shown in parenthesis. The most similar 3D7 DBLα tags were S20ICAM (PFL1950w), S20CD36 (PFI1820w), 99ICAM (PFL1950w), 99CD36 
(PFD1000c), 106ICAM (PFL1950w), 106CD36 (Mal6P1.316), 134ICAM (PFD0630c) and 134CD36 (PFD0995c). The x-axis numbers in each graph depict 
the sequences and the corresponding accessions can be retrieved in Supplementary data Fig. 4.
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that were connected to the severe var-associated domains 
DC8 and DC13 and the ICAM1 binding phenotype DC4 
in the seven P. falciparum genomes that were analysed 
by Rask et al. (2010). For this, we aligned the DBLα DNA 
sequences with sequences retrieved from their dataset. 
The sequence expressed in the CHO-CD36 selected S20 
line (S20CD36) expressed a DBLα tag similar to IT4var35, 
a sequence that is closely related to var1csa, while the 
dominant sequence in the CHO-CD36 selected line 99 
was identical to PFD1000c, which is an upsC1 type var 
gene (Rask et al. 2010). Because all of the remaining se-
quences from the 99 isolate were not similar to the 3D7 
counterparts, we concluded that no cross-contamination 
had occurred during the selection process, which was 
also true for all other tested isolates (Fig. 1). No other 
DBLα sequences showed significant similarity to DBLα 
domains, which were connected to DC8, DC13 or DC4 
domains from the published dataset from seven genomes 
(Rask et al. 2010), suggesting that they are most likely not 
part of the var genes encoding PfEMP1 containing this 
type of domain. We concluded that the produced pheno-
types, despite their apparent adherence to given CHO lines 
expressing ICAM1 or CD36, do not necessarily express 
PfEMP1, which can be related to any specific disease-as-
sociated phenotype. At a minimum, the selection of 3D7 
must have resulted in at least the marginal expression of 
either the PFD1235w or PF11_0521 var genes, which was 
not the case (Fig. 1, Supplementary data Fig. 4). There-
fore, it can only be assumed that the selected parasite phe-
notypes express distinct PfEMP1s, with the exception of 
the lines 106ICAM, S20ICAM and 99ICAM.
Flow cytometry analysis revealed a consistent pres-
ence of antibodies against the 3D7PFD0020c and 3D7Pf11_0521 
phenotypes - We tested the IRBC surface recognition of 
antibodies contained in plasma samples from 44 symp-
tomatic and 45 asymptomatic individuals. Immunofluo-
rescence assays revealed that IRBCs were recognised in 
a specific way and showed labelling only on the surface 
of IRBC, but not on normal RBCs. Additionally, no stain-
ing of parasites inside the IRBCs was observed (Supple-
mentary data Fig. 1). We then measured the recognition 
of field isolates/phenotypes by antibodies contained in 
the plasma of symptomatic and asymptomatic individu-
als by flow cytometry and calculated the RI for each 
plasma and parasite line tested. When we compared the 
percentage of positive plasma samples for parasite lines 
(RI higher than 1), we observed that the 3D7 isolates se-
lected for CHO-ICAM1 and CHO-CD36 were recognised 
by more plasma samples from asymptomatic individuals 
than those from symptomatic individuals (Fig. 2) (Fish-
er’s exact test, p = 0.0184 and p = 0.0079, respectively). 
However, recognition of the 3D7Pf11_0521 phenotype was 
more frequent in symptomatic individuals (p = 0.0148). 
No significant differences in the number of plasma sam-
ples recognising all other parasite lines were detected 
(p > 0.05) when comparing the recognition by plasma 
samples from symptomatic and asymptomatic individu-
als. When comparing the recognition of the different 
3D7 phenotypes by plasma samples from asymptomatic 
individuals, the 3D7Pf11_0521, 3D7ICAM and 3D7CD36 pheno-
types were less frequently recognised than 3D7PFD0020c 
(p < 0.0001). Most of the phenotypes, excluding the 
phenotype-selected 3D7 parasites, were recognised by 
40-80% of the plasma samples (Fig. 2). The 3D7PFD0020c 
lineage was recognised by the most plasma samples and 
it also had the highest RI (Fig. 2, Table I). In order to 
estimate the previous exposure of all of the individuals 
to malaria attacks, we measured antibodies against a re-
combinant version of the highly conserved C-terminus 
from merozoite protein 1 as a surrogate marker, given 
that the number of informed, previous malaria attacks 
was not predictive for a stronger or weaker recognition 
(Supplementary data, Table). As shown in Supplementa-
ry data (Table), the majority of individuals presented de-
tectable to high titres of antibodies against PfMSP119. On 
the other hand, low titres were not paralleled by a weak 
or absent reaction against the RBC surface, suggesting 
diversity in the response to malarial antigens. The same 
was true when comparing the number of informed infec-
tions with either titre level in the MSP119 ELISAs or IRBC 
recognition. We then individually analysed whether any 
of the phenotypes were recognised more strongly by 
plasma samples from either asymptomatic or symptom-
atic individuals. Significant differences and a stronger 
recognition (higher RI values) by plasma samples from 
asymptomatic individuals were indeed observed for the 
parasite lines S20CD36, 3D7PFD0020c, 3D7ICAM and 3D7CD36, 
while 134CD36 and 3D7Pf11_0521 had higher RI with plasma 
samples from symptomatic individuals. The remaining 
phenotypes were not differentially recognised by symp-
tomatic or asymptomatic donor plasma samples (Table 
II, Supplementary data Fig. 2). Additionally, we asked 
whether plasma samples recognised specifically more of 
the CHO-ICAM or the CHO-CD36 selected phenotype 
of each isolate. We also compared the recognition in-
tensities of the specific 3D7 phenotypes 3D7PFD0020c and 
3D7Pf11_0521 with their panned counterparts 3D7CD36 and 
3D7ICAM. Eventual differences here may inform about 
the relative participation of antiPfEMP1 antibodies in 
recognition when we assume that all other possibly ex-
posed variant antigens, such as RIFINs, STEVORs and 
Fig. 2: most plasma recognises the 3D7PFD0020c phenotype. The per-
centage of responders of each plasma donor group was plotted against 
the recognised parasite lineage. Asterisks mean significant differ-
ences between the percentages of recognising plasmas from the as-
ymptomatic and symptomatic group (Fisher’s exact test). 
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others, have either a smaller participation in recognition 
or are not differently expressed after the phenotype se-
lection process. Interestingly, in all cases, the ICAM1 
phenotype was more strongly recognised than the CD36 
phenotype, independently of the origin of the plasma. 
In the majority of cases, the difference in recognition 
was significantly different (Table I, Supplementary data 
Fig. 2). As was true for the percentage of plasma samples 
that reacted against this phenotype, the recognition of 
3D7PFD0020c was significantly higher in all plasma sam-
ples compared to the recognition of any other 3D7 phe-
notype. The phenotype 3D7Pf11_0521 was also very strong-
ly recognised. Both phenotypes were significantly more 
likely to be recognised than the other 3D7 phenotypes 
3D7CD36 and 3D7ICAM (Table I, Supplementary data Fig. 2), 
although plasma samples from asymptomatic carriers 
did not react differently against the 3D7Pf11_0521 pheno-
type compared to the 3D7ICAM or 3D7CD36 phenotypes.
The huge range of reactivity observed against the 
different 3D7 phenotypes expressing different alleles of 
PfEMP1, seen as the presence of dominant transcripts of 
the different var genes in the corresponding parasites, 
appears to highlight the importance of PfEMP1 recogni-
tion in the overall response against IRBC.
DISCUSSION
Antibodies directed to the surface of P. falciparum-
IRBC are important players in combating the symptoms 
and virulence of malaria and the recognition of PfEMP1 
seems to be of major importance (Bull et al. 1998, Chan 
et al. 2012). Many studies from epidemic sites in Africa 
and Southeast Asia have shown that the cumulative ac-
quisition of antibodies against a great number of anti-
genic phenotypes provides protection from malaria. The 
degree of acquired immunity ranges from protection 
initially from death, then from severe outcomes and fi-
nally from symptomatic malaria (Hviid 2005, Marsh & 
Kinyanjui 2006). As a consequence, it is believed that 
continuously exposed individuals do not necessarily 
suffer from malaria, but become asymptomatic carri-
ers. Additionally, it is hypothesised that during the first 
infections (at least in childhood malaria in Africa), a 
few conserved PfEMP1 phenotypes are expressed and 
lead to an increased severity of disease, which poten-
tially occurs via the mechanism postulated by Turner 
et al. (2013). The authors proposed that by blocking the 
interaction of soluble protein C through the binding of 
a DC8/DC13 PfEMP1 domain, endothelial activation 
is induced, which then leads to the up-regulation of in-
flammatory signals, including the increased expression 
of endothelial ICAM1 and other receptors. As a conse-
quence, the DC8/DC13 containing PfEMP1 phenotypes 
would be the first to be recognised by persons who did 
suffer severe malaria episodes. P. falciparum infection 
in the Brazilian Amazon is currently decreasing and 
transmission is unstable in many places. Symptomatic 
cases seem to accumulate in areas with a strong influx 
of non-immune populations, such as rural settlements, 
wood logging or mining activities (Oliveira-Ferreira et 
al. 2010). Perhaps as a consequence of low transmission 
and quick treatment, the overall diversity of variant pro-
TABLE I
Many plasma recognise more the CHO-ICAM selected  
lineage of parasites than the CHO-CD36 selected lineage 
p 
(plasmas 
symptomatic 
individuals)
p 
(plasmas 
asymptomatic 
individuals)
S20ICAM↑ vs. S20CD36 0.0085 0.9706
99ICAM↑ vs. 99CD36 0.0319 0.0137
106ICAM vs. 106CD36 0.0623 0.9005
134ICAM↑ vs. 134CD36 0.0359 0.8116
3D7PFD0020c vs. 3D7Pf11_0521↑ 0.3682 < 0.0001
3D7ICAM↑ vs. 3D7CD36 0.0446 0.0366
3D7PFD0020c↑ vs. 3D7ICAM < 0.0001 < 0.0001
3D7PFD0020c↑ vs. 3D7CD36 < 0.0001 < 0.0001
3D7Pf11_0521↑ vs. 3D7ICAM < 0.0001 0.3508
3D7Pf11_0521↑ vs. 3D7CD36 < 0.0001 0.2850
the significance of differences in reactivity indices of plasmas 
either from asymptomatic or symptomatic individuals reacting 
either against the CHO-ICAM or the CHO-CD36-selected para-
site lineage was evaluated by Mann-Whitney’s U test without 
normalisation of the data. Shown are the resulting p values. The 
arrows indicate which lineage was statistically more recognised. 
TABLE II
Comparison of reactivity indices (RI) from plasmas originating from asymptomatic  
and symptomatic individuals shows differing patterns of recognition
Tested  
parasite 
lineage S20ICAM S20CD36 99ICAM 99CD36 106ICAM 106CD36 3D7PFD0020c 3D7Pf11_0521 134ICAM 134CD36 3D7ICAM 3D7CD36
p 0.8417 0.0458 0.8310 0.8432 0.2331 0.5736 0.0100 0.0252 0.0707 0.0113 0.0023 0.0098
the significance of difference of the RI from asymptomatic and symptomatic patient’s plasmas reacting against the shown parasite 
lineages was evaluated using Mann-Whitney’s U test without normalisation of the data. Note that 134CD36 and 3D7Pf11_0521 were 
recognised stronger by plasmas from symptomatic infections.
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tein encoding genes, such as the var genes, in the Ama-
zon seems much smaller than in any other endemic area 
so far tested (Albrecht et al. 2006); development to severe 
malaria is also likely prevented by quick treatment. The 
herein used isolates possess var genes, which represent 
part of the repertoire of circulating strains in the Amazon 
(Albrecht et al. 2010). In order to elucidate the differen-
tial presence of antibodies against the IRBC surface in 
asymptomatic (“protected”) and symptomatic (“suscep-
tible”) individuals, we tested the recognition of P. falci-
parum isolates from the western Brazilian Amazon and 
compared them to four lineages of 3D7 that expressed 
different var genes/PfEMP1. These included the viru-
lence-associated phenotypes, which expressed either the 
var gene PFD0020c (Lavstsen et al. 2012, Turner et al. 
2013) or Pf11_0521, one of the ICAM1-binding PfEMP1 
variants of the 3D7 genome (Oleinikov et al. 2009).
For the preparation of relevant phenotypes in natu-
ral isolates, we tried to focus on two main cytoadher-
ent phenotypes that are supposedly expressed either in 
non-severe malaria (CD36 adherence) or severe malaria 
(ICAM1 adherence) (Ochola et al. 2011), although the 
latter possibly occurs in consequence to previous EP-
CR-adherence (Turner et al. 2013). We tried to prepare 
these phenotypes by panning the isolates over receptor-
transfected CHO cells (Hasler et al. 1993). Although 
our group had previously shown the usefulness of this 
quite economic cytoadherence selection approach using 
the 3D7 strain (Golnitz et al. 2008), this method cannot 
warrant that the selected parasites indeed use the most 
affine PfEMP1 for a defined receptor. One example is 
the 3D7 line selected on CHO-ICAM cells. Although the 
parasite line also showed the PFD1000c transcript, the 
dominant transcript was now PFL1970w (Fig. 1) and not 
PFF0845c, as described previously by us (Golnitz et al. 
2008). On the other hand, PfEMP1, which contains the 
most domains that bind strongly to ICAM1, is present 
in PF11_0521 (Oleinikov et al. 2009), although the upsA 
type PFD1235w also contains ICAM1 binding domains 
(Bengtsson et al. 2013). This means that other receptors 
- and not ICAM1 - seem to be recognised. Several is-
sues must be taken into account when using the assay 
employed in this study: first, there are additional recep-
tors on CHO cells, which can be recognised by PfEMP1 
domains (Andrews et al. 2005). Potentially the binding 
affinity to ICAM1 on the CHO-ICAM cells is not supe-
rior to the other unknown receptors present on the CHO 
cells, leading to varying dominant transcripts in differ-
ent experiments that use the CHO-ICAM cells. Given the 
var transcript sequence results from each parasite line 
panned over CHO-ICAM, we deduced that the method 
was not suitable for the directed selection of truly ICAM 
binding IRBCs. Second, the expression of the desired 
receptor molecules varied on the CHO-cell lines and 
frequent checks are necessary to assure that the recep-
tors are indeed still expressed. During our experiments, 
we checked whether the cells sufficiently expressed the 
respective receptor using specific antibodies against hu-
man CD36 and ICAM1 in immunofluorescence assays 
(data not shown). We also checked whether some isolates 
showed the most cytoadhesion to the CHO-cell line they 
were selected for. As depicted in Supplementary data 
Fig. 3, all isolates did adhere more to the cell line they 
were selected for, but they also showed cytoadherence to 
other CHO lines. The observation of simultaneous CD36 
and ICAM1-binding phenotypes has been documented 
before [for example, Scherf et al. (1998)]. In favour of 
the system used in this study, cytoadherence to receptors 
was partially inhibited by co-incubation with specific 
antibodies to CD36 and ICAM1 (data not shown). One 
alternative to cellular systems for cytoadherence selec-
tion would be the use of purified receptors, which has 
been done successfully by other groups, at least for CSA 
or ICAM1-binding parasite lines [see protocols published 
by J Reeder in Moll et al. (2008)]. We tried using com-
mercially available purified human ICAM1 spotted on 
plastic dishes, but the yields per selection round were too 
poor and this approach was abandoned (BC Carlos, un-
published observations). An additional concern regarding 
this method is the fact that naturally occurring receptors 
are embedded in or associated to membrane bilayers and 
are surrounded by vast arrays of glycosyl rests that are 
present on each cell surface. This is not the case when 
purified and recombinant receptors are used, which may 
consequently influence the cytoadherence strength.
After the panning selection using the field isolates, 
we observed dominant var transcripts in all parasite 
lines, indicating that we were potentially analysing phe-
notypically homogenous cultures. The DBLα-specific 
oligonucleotides used for the var transcript amplifica-
tion were previously used in a number of studies by us 
and others [e.g., Warimwe et al. (2009)] and permitted 
estimation of the corresponding sequences were asso-
ciated to specific ups (upsA, B and C) using the DSID 
analysis approach (Bull et al. 2007). Importantly, the var 
genes preceded by the upsA type sequences were found 
to be expressed in cases of severe malaria (Bull et al. 
2005, Warimwe et al. 2009), while the upsB and upsC 
sequences were not. The classification was greatly re-
fined with the analysis of the variant genes from seven 
P. falciparum genomes (Rask et al. 2010) and a novel 
quantitative PCR based approach now permits a rather 
detailed classification of var transcripts (Lavstsen et al. 
2012). When trying to classify the obtained field isolate 
transcripts, we observed that most of these fell into upsB 
and upsC types of transcripts (DSID types 4-6) and un-
expectedly, only the dominant sequences from S20CD36 
and 106CD36 presented the upsA type sequence. The iden-
tified sequence of S20CD36, however, was quite similar 
to the var1csa sequence [most similar to ITvar35, upon 
alignment to the dataset that was published in Rask et al. 
(2010)], which is a transcript consistently transcribed by 
many parasites, but apparently not encoding a functional 
PfEMP1 protein (Kyes et al. 2003). It is difficult to in-
terpret why CHO-CD36 panning induced a parasite line 
to express an upsA sequence type. Considering the pro-
cedure by which the isolates and the panned 3D7 strains 
were phenotypically selected for and given that the de-
tected var gene transcripts, with two exceptions, did not 
fall in the DSID groups that were associated with severe 
malaria cases, we suggest that the phenotypes we looked 
at will most likely not be found in severe cases in a field 
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situation, but in non-severe cases. When we monitored 
the antibody recognition of the different parasite lines, 
we observed a strong recognition of severe malaria-asso-
ciated phenotypes, such as the 3D7PFD0020c and 3D7Pf11_0521 
parasite lines. This indicates that the severe malaria as-
sociated DC8/DC13 phenotype is present and circulating 
in Amazonian isolates. This strong recognition occurred 
in a similar form with plasmas from symptomatic and 
asymptomatic individuals, although we did not detect 
antibodies in all samples. Following the hypothesis that 
the first malaria infections lead to more severe disease in 
non-immune carriers, which is characterised by the ex-
pression of var genes from the DC8 and DC13 groups, 
including PFD0020c (Avril et al. 2012, Claessens et al. 
2012, Lavstsen et al. 2012) and perhaps the DC4 group 
var genes (Bengtsson et al. 2013), one would expect that 
at least asymptomatic plasmas would contain specific 
antibodies for this phenotype. Potentially not all Ama-
zonian P. falciparum isolates contain severe malaria as-
sociated var genes or there may be antigenically very 
different, not yet described variants that we did not test 
in this study. The existence of a selection system that per-
mits purifying and enriching EPCR-binding phenotypes 
would be very useful to discover Amazonian severe var 
variants. However, it is possible that the severe var phe-
notype is only induced after a certain duration of infec-
tion and quick treatment (less than 48 h after onset) as is 
common in the Amazon would prevent the quantitative 
outgrowth of this phenotype. In consequence, these in-
dividuals would not necessarily react to the severe var 
phenotype. In one study, the controlled natural infection 
of non-immune individuals with the 3D7 strain led to the 
expression of severe var PFD0020c or PFD1235w in only 
two out of six volunteers only on days 3-4 after the onset 
of infection (Lavstsen et al. 2005).
Based on the analysis of the DBLα motifs, we have 
previously found that almost no sequences are shared 
between Amazonian isolates and the 3D7 strain (Al-
brecht et al. 2010). This finding may explain why the 
panned 3D7 lines that adhere to CD36 and ICAM1 and 
express non-PoLV1-3 (non upsA) type var genes were 
only weakly recognised by the plasma samples and sig-
nificantly less by the plasma samples from symptomatic 
patients. The recognition of the field isolates occurred 
in approximately 40-70% of each lineage by the plasma 
samples from each group, while the panned 3D7 vari-
ants were recognised much less frequently. As expected, 
the recognition of phenotypes was often stronger by the 
asymptomatic plasma samples. In previous studies, the 
reaction of antibodies against the IRBC surface was es-
timated using parasite lines that specifically expressed 
no PfEMP1 (PfEMP1 knockdown) or had impaired 
transport of PfEMP1 and other IRBC surface localised 
proteins (SBP-1 knockout). The knockdown of PfEMP1 
only decreased the IRBC surface recognition by antibod-
ies from a serum pool of malaria-experienced persons by 
approximately 70% compared to the normal PfEMP1-
displaying IRBCs (Voss et al. 2006). In the absence of 
other proteins besides PfEMP1 in the SBP-1 knockouts, 
there was a 90% decrease in IRBC surface recognition 
by immune sera (Maier et al. 2007). This indicates that a 
major portion of the antibodies against the IRBC surface 
is directed against the PfEMP1 proteins.
One of the goals of this study was to reveal whether 
the occurrence of asymptomatic malaria was paralleled 
by a significantly stronger presence of anti-IRBCs. 
While this was the case in recognition frequency and 
the antibody RI against many of the parasite lineages 
tested in this study, there were still a number of plasma 
samples in the asymptomatic group that reacted poorly 
against many phenotypes. This indicates that protection 
in these specific individuals is potentially quite fragile 
and is directed against a very limited repertoire of vari-
ant antigens, most of which were not present in this study. 
Another explanation is that the recognition of the IRBC 
surface is not crucial for the establishment of an asymp-
tomatic status, at least not under the transmission condi-
tions where the plasma donors lived. We did not test the 
IgG subclasses that reacted to the surface of the parasites 
and this may also be an important factor for achieving 
humoral immunity against the IRBC surface. A recent 
study using plasma samples from the same site tested the 
recognition of merozoite surface antigens in asymptom-
atic and symptomatic populations (Medeiros et al. 2013) 
and the authors observed similar patterns of recognition: 
while many of the asymptomatic patients recognised 
most of the antigens tested, a number of individuals did 
not recognise those antigens. Therefore, we propose that 
the recognition of many interchangeable targets may pro-
vide protection from symptoms under the transmission 
conditions of the western Amazon. The recent detection 
of EPCR as relevant receptor for cytoadherent IRBC 
(Turner et al. 2013) and the establishment of a system to 
quickly select for parasite phenotypes that express the se-
vere var related PfEMP1 should provide a useful tool to 
focus attention on the question of whether P. falciparum 
with decreased virulence exist, which could potentially 
provide a biological explanation for the virtual absence 
of severe malaria in the Brazilian Amazon.
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